IRIS
DICHIARA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 875
NA - Nord America 64
AF - Africa 28
AS - Asia 17
OC - Oceania 3
SA - Sud America 3
Totale 990
Salva come PNG Salva come JPEG
Nazione #
FR - Francia 714
IT - Italia 123
US - Stati Uniti d'America 48
CI - Costa d'Avorio 27
CA - Canada 16
CZ - Repubblica Ceca 8
ES - Italia 5
MY - Malesia 5
PL - Polonia 5
DE - Germania 4
IE - Irlanda 4
VN - Vietnam 4
AU - Australia 3
BR - Brasile 3
CN - Cina 3
FI - Finlandia 2
GB - Regno Unito 2
IN - India 2
NL - Olanda 2
PK - Pakistan 2
AT - Austria 1
BG - Bulgaria 1
GR - Grecia 1
NO - Norvegia 1
RO - Romania 1
SE - Svezia 1
SG - Singapore 1
TG - Togo 1
Totale 990
Salva come PNG Salva come JPEG
Città #
Paris 83
Catania 43
Abidjan 27
Halifax 16
Ashburn 8
Vittoria 8
Rome 5
Dublin 4
George Town 4
Padova 4
Aci Catena 3
Cottage Grove 3
Hobart 3
Milan 3
Syracuse 3
São Paulo 3
Albese Con Cassano 2
Boardman 2
Brandenburg 2
Brescia 2
Centro 2
Chandigarh 2
Dong Ket 2
Gilgit 2
Hampton 2
Hanoi 2
Helsinki 2
Lake Forest 2
Lipari 2
Philadelphia 2
Suffolk 2
Terrassa 2
Valencia 2
Warsaw 2
Ann Arbor 1
Barcelona 1
Basking Ridge 1
Brembate 1
Camerino 1
Castello di Godego 1
Council Bluffs 1
Craiova 1
Enna 1
Frankfurt am Main 1
Gorla Minore 1
Houston 1
Lomé 1
Maletto 1
Messina 1
Modena 1
Nicolosi 1
Novara 1
Oslo 1
Palermo 1
Parsippany 1
Pasadena 1
Paternò 1
Pizzo 1
Rimini 1
Saint Albans 1
San Jose 1
San Mateo 1
Santa Maria di Sala 1
Settingiano 1
Sofia 1
Tarquinia 1
Thessaloniki 1
Troina 1
Verona 1
Vienna 1
Wołomin 1
Totale 293
Salva come PNG Salva come JPEG
Nome #
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore, file e15da8b7-5cd5-4402-a73d-74ba2856ea42 695
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands, file dfe4d229-8912-bb0a-e053-d805fe0a78d9 100
Sigma-2 receptor ligands QSAR model dataset, file dfe4d227-df3b-bb0a-e053-d805fe0a78d9 24
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors, file dfe4d228-8414-bb0a-e053-d805fe0a78d9 22
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity, file dfe4d22e-96aa-bb0a-e053-d805fe0a78d9 16
Repurposing of human kinase inhibitors in neglected protozoan diseases, file dfe4d228-8263-bb0a-e053-d805fe0a78d9 14
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity, file fe5420ee-d461-4cae-a84e-7bc26d42506f 11
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands, file 6db428fa-2b5c-4ccb-a8b9-c2dd16f669ab 9
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation, file dfe4d22b-e2ea-bb0a-e053-d805fe0a78d9 9
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma, file dfe4d22e-52b1-bb0a-e053-d805fe0a78d9 9
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain, file 19b960fa-bdf0-4a9b-a675-1cd31140f124 8
CNS permeability parameters determination through a statistical analysis driven approach, file dfe4d229-efd7-bb0a-e053-d805fe0a78d9 7
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity, file e24768af-b1a1-41fd-8f0a-3fa79561f01f 7
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain, file 27e3a036-d724-4d51-9242-ad75ac53e98b 5
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist, file dfe4d22a-eed3-bb0a-e053-d805fe0a78d9 5
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity, file dfe4d228-8444-bb0a-e053-d805fe0a78d9 4
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors, file dfe4d228-8ada-bb0a-e053-d805fe0a78d9 4
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity, file f9f8dca3-6ec7-4221-9c41-4760b5c358e4 4
Composti inorganici [Cap. 6], file dfe4d228-92b1-bb0a-e053-d805fe0a78d9 3
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer, file dfe4d229-0a61-bb0a-e053-d805fe0a78d9 3
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines, file dfe4d229-5b0e-bb0a-e053-d805fe0a78d9 3
Development of novel H2S-donor sigma receptor hybrids for the management of pain., file dfe4d229-cad6-bb0a-e053-d805fe0a78d9 3
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties, file dfe4d22e-c01d-bb0a-e053-d805fe0a78d9 3
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review, file dfe4d228-68cb-bb0a-e053-d805fe0a78d9 2
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics, file dfe4d228-83ce-bb0a-e053-d805fe0a78d9 2
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis, file dfe4d228-8510-bb0a-e053-d805fe0a78d9 2
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents, file dfe4d228-8512-bb0a-e053-d805fe0a78d9 2
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders, file dfe4d229-75b3-bb0a-e053-d805fe0a78d9 2
Development of NO-releasing sigma receptor hybrids as anticancer agents, file dfe4d229-c844-bb0a-e053-d805fe0a78d9 2
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands, file 55ff06b0-72d2-41f1-85f5-27687e92977c 1
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands, file 61713f9d-aa40-4ca6-9f1a-63a80ea247ea 1
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists, file af56fd43-07a1-4236-ad34-51fe9af5fc09 1
H2S releasing molecules in pharmaceutical development, file c6c9e0bb-7043-4b00-a7bd-d4e2347fb661 1
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands, file dfe4d228-7eb4-bb0a-e053-d805fe0a78d9 1
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents, file dfe4d228-7eb8-bb0a-e053-d805fe0a78d9 1
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect, file dfe4d228-8ade-bb0a-e053-d805fe0a78d9 1
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties, file dfe4d228-9535-bb0a-e053-d805fe0a78d9 1
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new?, file dfe4d228-bf4f-bb0a-e053-d805fe0a78d9 1
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis, file dfe4d229-0d66-bb0a-e053-d805fe0a78d9 1
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus, file dfe4d229-8ef9-bb0a-e053-d805fe0a78d9 1
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists, file dfe4d22a-f2a8-bb0a-e053-d805fe0a78d9 1
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation, file dfe4d22e-c01c-bb0a-e053-d805fe0a78d9 1
Totale 993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 1 0 0 3 0 0
2020/202121 10 0 0 2 1 0 1 0 2 1 1 3
2021/202250 3 1 3 2 2 5 6 7 12 4 4 1
2022/202391 4 1 3 2 13 7 10 3 10 2 22 14
2023/2024820 6 10 2 0 9 416 111 246 12 8 0 0
Totale 993